Adial Pharmaceuticals Inc - Asset Resilience Ratio

Latest as of September 2018: 0.00%

Adial Pharmaceuticals Inc (ADIL) has an Asset Resilience Ratio of 0.00% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore total assets of Adial Pharmaceuticals Inc for the complete picture of this company's asset base.

Liquid Assets

$0.00

Cash + Short-term Investments

Total Assets

$5.25 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Adial Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. See net asset quality index of Adial Pharmaceuticals Inc to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Adial Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ADIL market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$0.00	0%
Total Liquid Assets	$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Adial Pharmaceuticals Inc maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Adial Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio

Compare Adial Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Royalty Pharma Plc NASDAQ:RPRX	Biotechnology	0.11%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%
Hyundai Bioscience Co. Ltd KQ:048410	Biotechnology	13.57%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	82.25%
Lifecome Biochemistry Co Ltd SHE:002868	Biotechnology	4.69%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%

Annual Asset Resilience Ratio for Adial Pharmaceuticals Inc (None–None)

The table below shows the annual Asset Resilience Ratio data for Adial Pharmaceuticals Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Adial Pharmaceuticals Inc

NASDAQ:ADIL USA Biotechnology

Market Cap

$3.41 Million

Market Cap Rank

#29862 Global

#5928 in USA

Share Price

$2.39

Change (1 day)

+6.70%

52-Week Range

$0.14 - $3.12

All Time High

$208.25